Cargando…
Striatal Infusion of Glial Conditioned Medium Diminishes Huntingtin Pathology in R6/1 Mice
Huntington's disease is a neurodegenerative disorder caused by an expansion of CAG repeats in the huntingtin gene which produces widespread neuronal and glial pathology. We here investigated the possible therapeutic role of glia or glial products in Huntington's disease using striatal glia...
Autores principales: | Perucho, Juan, Casarejos, Maria José, Gómez, Ana, Ruíz, Carolina, Fernández-Estevez, Maria Ángeles, Muñoz, Maria Paz, de Yébenes, Justo García, Mena, Maria Ángeles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3771920/ https://www.ncbi.nlm.nih.gov/pubmed/24069174 http://dx.doi.org/10.1371/journal.pone.0073120 |
Ejemplares similares
-
Protection by glia-conditioned medium in a cell model of Huntington disease
por: Ruiz, Carolina, et al.
Publicado: (2012) -
Trehalose Reverses Cell Malfunction in Fibroblasts from Normal and Huntington's Disease Patients Caused by Proteosome Inhibition
por: Fernandez-Estevez, Maria Angeles, et al.
Publicado: (2014) -
Trehalose Improves Human Fibroblast Deficits in a New CHIP-Mutation Related Ataxia
por: Casarejos, Maria Jose, et al.
Publicado: (2014) -
The striatal kinase DCLK3 produces neuroprotection against mutant huntingtin
por: Galvan, Laurie, et al.
Publicado: (2018) -
A striatal-enriched intronic GPCR modulates huntingtin levels and toxicity
por: Yao, Yuwei, et al.
Publicado: (2015)